 Event
detail
|
| Dates
: |
From
31/03/2008 to 02/04/2008 |
| Title
: |
Thirteenth Arden House European Conference: Driving
innovation, control and performance improvement on the critical path
- the pivotal role of particle powder and powder technologies in
dosage form manufacture |
|
Reference: |
The 2008 Arden House
European conference is a three-day conference presented by the Royal
Pharmaceutical Society of Great Britain (RPSGB), the Academy of
Pharmaceutical Sciences (APS) and the American Association of
Pharmaceutical Scientists (AAPS). The drive for signifi cant step
change in the industry's manufacturing performance continues to
highlight the limited understanding and critical importance of the
physical characteristics of both APIs and excipients, and their
process interactions, on manufacturing and ultimately clinical
performance. The introduction of ICH guidelines Q8 and Q10 indicate
that quality cannot be tested into products and provide the
necessary driver to ensure processes are under control and the
concept of 'quality by design' will become commonplace in the
industry. There is now no doubt that particle and powder
technologies will play an increasingly key role in bridging the
current process understanding and performance gap that exists
between API and Drug Product Manufacture and the even more complex
processing requirements of combination presentations predicted in
the future.
|
|
Location : |
London
(UK) |
|
Contact : |
Science
Inquiries |
| Phone
: |
+442075722261 |
| Fax : |
+442075722506 |
|
E-mail : |
science@rpsgb.org |
| More
info : |
http://www.rpsgb.org/worldofpharmacy/events |
| |
 back |
|
